BioXcel Therapeutics, Inc.
BTAI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60 | -$179 | -$166 | -$107 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $19 | $17 | $19 |
| Change in WC | -$6 | $2 | $10 | $5 |
| Other Non-Cash | -$13 | $3 | $2 | $0 |
| Operating Cash Flow | -$72 | -$155 | -$135 | -$82 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | $0 | $99 | $0 |
| Stock Issued | $40 | $27 | $0 | $101 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$1 | -$2 | $1 |
| Financing Cash Flow | $37 | $27 | $96 | $102 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$35 | -$129 | -$39 | $20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65 | $194 | $233 | $213 |
| End Cash | $30 | $65 | $194 | $233 |
| Free Cash Flow | -$72 | -$155 | -$135 | -$83 |